This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kleinke, J.D. Search for Related Content PubMed PubMed Citation Articles by Kleinke, J.D. Related Collections Pharmaceuticals Health Spending

Value Of Innovation

The Price Of Progress: Prescription Drugs In The Health Care Market

Pharmacy costs are rising in excess of general and medical cost inflation, leading to calls for price and utilization controls by public and private payers. Such controls would be ineffective and counterproductive because they would attempt to reverse two profound, historic phenomena at work in the U. S. health care system. The added costs associated with breakthrough medicines represent a major structural shift from the provision of traditional medical services to the consumption of medical products; they also represent the creation of economic, social, and public health utility that we value as a society. The balkanization of medical delivery, institutionalized under traditional reimbursement strategies and galvanized by federal law, does not adequately account for or efficiently accommodate this rotation and increased utility. Federal and state laws regulating health insurance and provider risk sharing need to be revamped to encourage rather than constrain the social progress embodied in expensive, breakthrough medical technologies.

                      What's this?

This article has been cited by other articles:

				F. Simon Market Access For Biopharmaceuticals: New Challenges Health Aff., September 1, 2006; 25(5): 1363 - 1370. [Abstract] [Full Text] [PDF]

				E. S. Fisher, D. E. Wennberg, T. A. Stukel, D. J. Gottlieb, F. L. Lucas, and E. L. Pinder The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care Ann Intern Med, February 18, 2003; 138(4): 273 - 287. [Abstract] [Full Text] [PDF]

				E. S. Fisher, D. E. Wennberg, T. A. Stukel, D. J. Gottlieb, F. L. Lucas, and E t. L. Pinder The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care Ann Intern Med, February 18, 2003; 138(4): 288 - 298. [Abstract] [Full Text] [PDF]